T2 Biosystems, Inc. ( TTOO) - Key Metrics
TTOO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | $0.11 | -$0.57 | -$0.35 | -$0.35 |
| 2024Q2 | $0.14 | -$0.64 | -$0.66 | -$0.66 |
| 2024Q1 | $0.41 | -$2.66 | -$2.30 | -$2.30 |
| 2023Q4 | $0.34 | -$2.08 | -$1.89 | -$1.90 |
| 2023Q3 | $0.33 | -$3.45 | -$2.99 | -$2.99 |
TTOO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | ? | -0.87 |
| 2024Q2 | ? | -2.12 |
| 2024Q1 | ? | -0.28 |
| 2023Q4 | ? | -0.75 |
| 2023Q3 | ? | -1.60 |
TTOO
Price: $0
52 week price:
Earnings Per Share: -0.03 USD
P/E Ratio: -0.10
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 168600
Ebitda: -11.7 millionMarket Capitalization: 14023